Bayer HealthCare has a lifetime commitment to improving and extending the lives of our patients. Bayer HealthCare is involved in research activities to improve therapies and advance patient care.
Recent news from Bayer HealthCare can be found in these press releases.
Bayer HealthCare Awards Grant to Support Future Leaders of Bleeding Disorders Community
|
| |
 |
| |
Bayer HealthCare Enhances Data Collection of EZ-Log Patient Electronic Diary
|
| |
|
| |
Bayer HealthCare and BioRx Support New Educational Book for Children with Hemophilia
|
| |
|
| |
Search Begins for 2008 Hemophilia Leadership Development Program Intern
|
| |
|
| |
Five U.S. Physicians Receive Grants from Bayer to Continue Hemophilia Research
|
| |
|
| |
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate FS Treatments
|
| |
|
| |
IndyCar Series Season Drives New Support for Marco Andretti and Team Hemophilia
|
| |
|
| |
Bayer HealthCare Awards Grant to National Hemophilia Foundation's Youth Leadership Institute
|
| |
|
| |
Bayer HealthCare and BioRx Introduce Educational Children's Book About Hemophilia
|
| |
|
| |
Bayer HealthCare Introduces Free Product Trial Program For Kogenate® FS with BIO-SET®
|
| |
|
| |
Bayer HealthCare, The National Hemophilia Foundation, and Andretti Green Racing Announce Racing for Hemophilia Primary Donor for the 2006 Indianapolis 500
|
| |
|
| |
Five U.S. Physicians Among 26 Awardees Worldwide to Receive Grants From Bayer HealthCare Pharmaceuticals to Continue Cutting-Edge Hemophilia Research
|
| |
|
| |
3rd Generation Andretti Will Race at Indianapolis 500 to Support Racing for Hemophilia Fundraising Program
|
| |
|
| |
Bayer HealthCare Introduces Kogenate® FS with BIO-SET® in the
United States
|
| |
|
| |
Bayer Introduces New and Improved Infusion Set for Kogenate® FS
|
| |
|
| |
Bayer Receives FDA Approval for Room Temperature Storage of
Kogenate® FS
Oct. 10, 2005 — The Biological Products Division of Bayer HealthCare, LLC., (Bayer BP) announced today that Kogenate® FS (Antihemophilic Factor [Recombinant], Formulated with Sucrose) received approval to be stored at room temperature (77° F, 25° C) for up to three months. The new storage guidelines for the treatment will provide users with greater flexibility and simplify storage options.
|
| |
|
| |
In the aftermath of Hurricane Katrina Bayer pledges US$ 2 million
for flood victims
Sep. 06, 2005 —
In light of the devastation caused by Hurricane Katrina along the Gulf Coast of the United States,
Bayer has pledged US$ 2 million to the U.S. Red Cross.
|
| |
|
| |
Bayer Biological Products Introduces Free Product Trial For Kogenate® FS
|
| |
|
| |
Bayer Biological Products Signs Exclusive Agreement with World Federation of Hemophilia to Fund International Nursing Fellowship Program
Apr. 18, 2005 — Berkeley, Calif. (April 15, 2005) Bayer Biological Products (BP) announced today the launch of the World Federation of Hemophilia's (WFH) International Hemophilia Nursing Fellowship Program, a new fellowship program providing state-of-the-art hemophilia education and training to nurses in developing countries. The program will extend the benefits of WFH's highly successful International Hemophilia Treatment Center Fellowship program by providing training opportunities for nurses, critically important members of the hemophilia treatment team.
|
| |
|
| |
Bayer Biological Products Launches New Global Headquarters, Announces Senior Leadership Team for Division
|
| |
|
| |
New Kogenate® FS Web Site Launched by Bayer Biological Products
|
| |
|
| |
Kogenate® FS Donated by Bayer Biological Products to
World Federation of Hemophilia
Feb. 24, 2005 — Donation expected to assist hundreds of people living with hemophilia in 13 countries
|
| |
|
| |
Bayer To Divest its Plasma Products Business To US Investors
Cerberus and Ampersand
Kogenate® product line will remain in Bayer's portfolio
Dec. 13, 2004 — Bayer AG today announced that an agreement has been signed
to contribute the assets of its worldwide plasma products business to NPS BioTherapeutics, Inc., a newly formed corporation controlled by affiliates of Cerberus Capital Management, L.P., New York, and Ampersand Ventures, Wellesley,
Massachusetts.
|
| |
|
| |
Bayer Signs Development Deal for Longer-Acting Kogenate®
Nov. 22, 2004 — Breakthrough liposome technology may allow new treatment paradigm of once weekly dosing in hemophilia A
|
| |
|
| |
2004 Bayer Hemophilia Awards Program Recipients Honored at World Federation of Hemophilia Congress
Oct. 21, 2004 — Research and education grants provided to 26 worldwide hemophilia professionals
|
| |
|
| |
New Adult Hemophilia Quality of Life Tool Now Available for Hemophilia Community
Oct. 20, 2004 — Multinational validation study of Haemo-QoL-A presented at WFH Congress
|
| |
|
| |
WFH Special Symposium Emphasizes Shifting Paradigms in Hemophilia Treatment
Oct. 20, 2004 — Bayer BP-supported program presents current issues and explores advances representing the future state-of-the-art in hemophilia care
|
| |
|
| |
Bayer Biological Products Launches Initiative to Aid Kogenate® FS Patients
Aug. 04, 2004 — Multi-faceted patient assistance initiative developed in response to community needs
|
| |
|
| |
Bayer Biological Products Extends Support of Landmark Study in Prophylactic Treatment of Hemophilia A
Jul. 13, 2004 — Financial support will extend unique seven-year study with Kogenate® FS, generating unprecedented treatment information for young boys
|
| |
|
| |
Bayer Biological Products Donates Kogenate® FS to World Federation of Hemophilia
Jun. 28, 2004 — Donation representing more than $9.3 million expands Bayer's outreach to developing countries
|
| |
|
| |
Bayer Biological Products Helps World Federation of Hemophilia Launch International External Quality Assessment Scheme (IEQAS)
Apr. 15, 2004 — World Hemophilia Day commemorative grant will support initiative to create "universal standard" for hemophilia laboratory performance
|
| |
|
| |
Bayer Biological Products Receives Award at Society of Thrombosis and Hemostasis Meeting in Germany
Apr. 05, 2004 — Early research to develop longer-lasting recombinant factor VIII molecule recognized among best conference presentations
|
| |
|
| |
